Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Kishore Gnana Sam"'
Autor:
Syed Wasif Gillani, Kishore Gnana Sam, Fithawit Bahran Gebreigziabher, Jumana Al-Salloum, Rizah Anwar Assadi, Shabaz Mohiuddin Gulam
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 10, Iss 2, Pp 102-105 (2021)
Centre of advanced pharmaceutical education have developed 15 subsets of competencies required to be competent pharmacist and able to provide optimum care. These competencies were further categorized; Level 1 intermediate, Level 2 efficient, and Leve
Externí odkaz:
https://doaj.org/article/fc2316247a7f49cbafbf8c067551333a
Autor:
Maitha Abdul-Aziz Al-Tamimi, Syed Wasif Gillani, Mohamed Elhassan Abd Alhakam, Kishore Gnana Sam
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Heart failure (HF) is a significant cause of mortality, morbidity and impaired quality of life and is the leading cause of readmissions and hospitalization. This study aims to identify the factors contributing to readmission in patients w
Externí odkaz:
https://doaj.org/article/649481ca3d6a42e9a9e478ccff7ce2a2
Publikováno v:
Research Journal of Pharmacy and Technology. :4265-4269
Background: Schizophrenia is a burdensome illness which virtually affects all aspects of the patient’s life. There is a lack of national level data from India on prescription pattern of Antipsychotics Polypharmacy and other drugs combination in the
Autor:
Semira Abdi Beshir, Hossam Hamdy, Dixon Thomas, Seeba Zachariah, Kishore Gnana Sam Sundararaj
Publikováno v:
Pharmacy Education. 20:196-204
Background: Reports on using virtual patients to assess counselling skills is scarce. Aim: This paper describes the feasibility and acceptability of assessing patient counselling skills of pharmacy students using a virtual patient simulator. Descript
Autor:
Asim Ahmed Elnour, Adel Sadeq, Farah Hamad Farah, Azza Ramadan, Mohamed A. Baraka, Judit Don, Abdulla Al Amoodi, Kishore Gnana Sam, Nadia Al Mazrouei, Maisoun Alkaabi
Publikováno v:
Current reviews in clinical and experimental pharmacology.
Background: A subpopulation of statin users such as subjects with chronic kidney disease (CKD), Human Immune virus (HIV, acute coronary syndrome (ACS), revascularization, metabolic syndrome, and/or diabetes may particularly benefit from pitavastatin
Publikováno v:
International journal of clinical practiceREFERENCES. 75(9)
AIMS Globally, hypertension is a major concern in all health care systems. The role of clinical pharmacists in managing hypertension is essential not only in dispensing drugs but also in actively participating in managing treatment regimens. The goal
Autor:
Shabaz Mohiuddin Gulam, Rizah Anwar Assadi, Fithawit Bahran Gebreigziabher, Kishore Gnana Sam, Syed Wasif Gillani, Jumana Al-Salloum
Publikováno v:
Journal of Research in Pharmacy Practice
Journal of Research in Pharmacy Practice, Vol 10, Iss 2, Pp 102-105 (2021)
Journal of Research in Pharmacy Practice, Vol 10, Iss 2, Pp 102-105 (2021)
Centre of advanced pharmaceutical education have developed 15 subsets of competencies required to be competent pharmacist and able to provide optimum care. These competencies were further categorized; Level 1 intermediate, Level 2 efficient, and Leve
Autor:
Syed Wasif Gillani, Dixon Thomas, Kishore Gnana Sam, Shabaz Mohiuddin Gulam, Fithawit Bahran Gebreigziabher, Rizah Anwar Assadi, Jumana Al-Salloum
Publikováno v:
Current drug safety. 16(3)
Objective: This systematic review aims to investigate the role and responsibilities of pharmacists in the prevention of medication errors. The study also aims to evaluate pharmacist-centered strategies that have an impact on medication error reductio
Autor:
Israa Yousif Khidir, Sahar Asim, Asim Ahmed Elnour, András Komócsi, Péter Kupó, Kishore Gnana Sam, Seeba Zachariah, Adel Sadeq
Publikováno v:
Current reviews in clinical and experimental pharmacology. 16(1)
Background: Despite the developments of single or dual antiplatelet therapy consisting of aspirin and/or clopidogrel, prasugrel or ticagrelor, post-acute coronary syndrome a room for potential improvement towards optimal prevention persist. The addit
Autor:
Jason C. Cooper, Seeba Zachariah, Matthew Van Cuyk, Zoya Ali, Dixon Thomas, Kishore Gnana Sam Sundararaj
Publikováno v:
American Journal of Cardiovascular Drugs. 17:343-346
Non-steroidal anti-inflammatory drugs (NSAIDs) were differentiated from steroidal anti-inflammatory medicines to help clinicians who needed to use anti-inflammatory agents that were safer than steroids. With market entry of rofecoxib in 1999, NSAIDs